Evaluation of retinoic acid therapy for OTX2-positive medulloblastomas

Neuro-Oncology

Volumn 12, Issue 7, 2010, Pages 655-663

  Bai, Renyuan ^a   Siu, I Mei ^a   Tyler, Betty M ^a   Staedtke, Verena ^a   Gallia, Gary L ^a   Riggins, Gregory J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FGF; Medulloblastoma; OTX2; Retinoic acid

Indexed keywords

ALITRETINOIN; CASPASE; FIBROBLAST GROWTH FACTOR; TRANSCRIPTION FACTOR OTX2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DNA FLANKING REGION; DOWN REGULATION; FEMALE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MEDULLOBLASTOMA; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PLASMID; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; FEMALE; MEDULLOBLASTOMA; MICE; MICE, NUDE; OTX TRANSCRIPTION FACTORS; TRETINOIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 78650292304     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nop062     Document Type: Article

References (29)

1. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumorsof thenervous system. JNeuropathol ExpNeurol.2002;61:215-225.
2. Palmer SL, Reddick WE, Gajjar A. Understanding the cognitive impact on children who are treated for medulloblastoma. J Pediatr Psychol. 2007;32:1040-1049.
3. Yokota N, Mainprize TG, Taylor MD, et al. Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization. Oncogene. 2004;23: 3444-3453.
4. Boon K, Eberhart CG, Riggins GJ. Genomic amplification of orthodenticle homologue 2 in medulloblastomas. Cancer Res. 2005:65: 703-707.
5. Di C, Liao S, Adamson DC, et al. Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans-retinoic acid. Cancer Res. 2005;65:919-924.
6. de Haas T, Oussoren E, Grajkowska W, et al. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas. J Neuropathol Exp Neurol. 2006;65:176-186.
7. Michiels EM, Oussoren E, Van Groenigen M, et al. Genes differentially expressed in medulloblastoma and fetal brain. Physiol Genomics. 1999;1:83-91.
8. Northcott PA, Nakahara Y, Wu X, et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet. 2009;41:465-472.
9. Simeone A. Otx1 and Otx2 in the development and evolution of the mammalian brain. Embo J. 1998;17:6790-6798.
10. Frantz GD, Weimann JM, Levin ME, McConnell SK. Otx1 and Otx2 define layers and regions in developing cerebral cortex and cerebellum. J Neurosci. 1994;14:5725-5740.
11. Wu Q, Chen ZM, Su WJ. Anticancer effect of retinoic acid via AP-1 activity repression is mediated by retinoic acid receptor alpha and beta in gastric cancer cells. Int J Biochem Cell Biol. 2002;34:1102-1114.
12. Reynolds CP, Matthay KK, Villablanca JG, Maurer BJ. Retinoid therapy of high-risk neuroblastoma. Cancer Lett. 2003;197:185-192.
13. Recchia F, Saggio G, Cesta A, et al. Interleukin-2 and 13-cis retinoic acid as maintenance therapy in advanced ovarian cancer. Int J Oncol. 2005;27:1039-1046.
14. Simeone A, Acampora D, Mallamaci A, et al. A vertebrate gene related to orthodenticle contains a homeodomain of the bicoid class and demarcates anterior neuroectoderm in the gastrulating mouse embryo. EMBO J. 1993;12:2735-2747.
15. Hallahan AR, Pritchard JI, Chandraratna RA, et al. BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat Med. 2003;9:1033-1038.
16. Bai RY, Dieter P, Peschel C, Morris SW, Duyster J. Nucleophosminanaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity. Mol Cell Biol. 1998;18:6951-6961.
17. Thompson RC, Pardoll DM, Jaffee EM, et al. Systemic and local paracrine cytokine therapies using transduced tumor cells are synergistic in treating intracranial tumors. J Immunother Emphasis Tumor Immunol. 1996;19:405-413.
18. Miller VA, Benedetti FM, Rigas JR, et al. Initial clinical trial of a selective retinoid X receptor ligand, LGD1069. J Clin Oncol. 1997;15:790-795.
19. Cheng C, Michaels J, Scheinfeld N. Alitretinoin: a comprehensive review. Expert Opin Investig Drugs. 2008;17:437-443.
20. Kurlandsky SB, Gamble MV, Ramakrishnan R, Blaner WS. Plasma delivery of retinoic acid to tissues in the rat. J Biol Chem. 1995;270:17 850-17 857.
21. Werner EA, Deluca HF.Retinoic acidisdetectedat relatively highlevels in the CNS of adult rats. Am J Physiol EndocrinolMetab. 2002;282:E672-E678.
22. Varani J, Fligiel H, Zhang J, et al. Separation of retinoid-induced epidermal and dermal thickening from skin irritation. Arch Dermatol Res. 2003;295:255-262.
23. Ponthan F, Borgstrom P, Hassan M, et al. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo. Med Pediatr Oncol. 2001;36:127-131.
24. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396-401.
25. Mohammadi M, Froum S, Hamby JM, et al. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J. 1998;17:5896-5904.
26. Kawamata H, Tachibana M, Fujimori T, Imai Y. Differentiation-inducing therapy for solid tumors. Curr Pharm Des. 2006;12:379-385.
27. Diez del Corral R, Breitkreuz DN, Storey KG. Onset of neuronal differentiation is regulated by paraxial mesoderm and requires attenuation of FGF signalling. Development. 2002;129:1681-1691.
28. Diez del Corral R, Olivera-Martinez I, Goriely A, et al. Opposing FGF and retinoid pathways control ventral neural pattern, neuronal differentiation, and segmentation during body axis extension. Neuron. 2003;40:65-79.
29. Gonzalez AM, Berry M, Maher PA, Logan A, Baird A. A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain. Brain Res. 1995;701:201-226.